Literature DB >> 28899606

Is tissue engineering of patient-specific oral mucosa grafts the future of urethral reconstruction?

Hans M Larsson1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28899606      PMCID: PMC5652003          DOI: 10.1016/j.ebiom.2017.09.006

Source DB:  PubMed          Journal:  EBioMedicine        ISSN: 2352-3964            Impact factor:   8.143


× No keyword cloud information.
  6 in total

1.  Reply to Nadir I. Osman, Christopher R. Chapple, Sheila MacNeil's Letter to the Editor re: Guido Barbagli, Massimo Lazzeri. Clinical Experience with Urethral Reconstruction Using Tissue-engineered Oral Mucosa: A Quiet Revolution. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.043.

Authors:  Guido Barbagli; Massimo Lazzeri
Journal:  Eur Urol       Date:  2015-08-07       Impact factor: 20.096

2.  Urethral tissue regeneration using collagen scaffold modified with collagen binding VEGF in a beagle model.

Authors:  Weisheng Jia; He Tang; Jianjian Wu; Xianglin Hou; Bing Chen; Wei Chen; Yannan Zhao; Chunying Shi; Feng Zhou; Wei Yu; Shengquan Huang; Gang Ye; Jianwu Dai
Journal:  Biomaterials       Date:  2015-08-05       Impact factor: 12.479

3.  Cell-seeded tubularized scaffolds for reconstruction of long urethral defects: a preclinical study.

Authors:  Hazem Orabi; Tamer AbouShwareb; Yuanyuan Zhang; James J Yoo; Anthony Atala
Journal:  Eur Urol       Date:  2012-07-31       Impact factor: 20.096

4.  Re: Guido Barbagli, Massimo Lazzeri. Clinical Experience with Urethral Reconstruction Using Tissue-engineered Oral Mucosa: A Quiet Revolution. Eur Urol 2015;68:917-918.

Authors:  Nadir I Osman; Christopher R Chapple
Journal:  Eur Urol       Date:  2015-12-03       Impact factor: 20.096

5.  Oral complications after buccal mucosal graft harvest for urethroplasty.

Authors:  Norman Dublin; Laurence H Stewart
Journal:  BJU Int       Date:  2004-10       Impact factor: 5.588

6.  Results of Use of Tissue-Engineered Autologous Oral Mucosa Graft for Urethral Reconstruction: A Multicenter, Prospective, Observational Trial.

Authors:  Gouya Ram-Liebig; Guido Barbagli; Axel Heidenreich; Dirk Fahlenkamp; Giuseppe Romano; Udo Rebmann; Diana Standhaft; Hermann van Ahlen; Samer Schakaki; Ulf Balsmeyer; Maria Spiegler; Helmut Knispel
Journal:  EBioMedicine       Date:  2017-08-16       Impact factor: 8.143

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.